Hovione
Brendan Mooney has extensive work experience in the engineering and maintenance field. Brendan is currently working as the Head of Engineering and Maintenance at BioCentriq since February 2023. Prior to this, they held the position of Director of Engineering and Maintenance at Hovione starting in August 2022.
From 2008 to 2022, Brendan worked at Eli Lilly and Company, where they held the role of Director of Plant Engineering. Before joining Eli Lilly, they worked at ImClone Systems, a subsidiary of Eli Lilly, as a Senior Engineer from 2000 to 2008. Prior to that, Brendan worked at BASF as a Senior Engineer from 1998 to 2000, and at Knoll Pharmaceutical Company as a Senior Project Engineer from 1991 to 1998.
Brendan Mooney holds a BSME degree in Mechanical Engineering from the New Jersey Institute of Technology. Brendan is also a Licensed Professional Engineer in the state of New Jersey.
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.